Psoriasis
Conference Coverage
Apremilast succeeds against nail, scalp, palmoplantar psoriasis
Key clinical point: Apremilast significantly improved psoriasis in a subset of patient with nail, scalp, and palmoplantar involvement. Major...
Conference Coverage
VIDEO: Don’t discount topical therapy for psoriasis
News
Psoriasis patients’ QOL improved with calcipotriene/betamethasone
Key clinical point: Calcipotriene 0.005% plus betamethasone diproprionate 0.064% was safe and effective and improved patients’ perceived quality...
Conference Coverage
Novel psoriasis biologic wows with jaw-dropping results
Key clinical point: Up to 66 months after receiving a single subcutaneous injection of a biologic agent that selectively blocks interleukin-23,...
News
Severe diaper rash, cradle cap raise suspicion for pediatric psoriasis
Conference Coverage
Psoriasiform lesions linked to anti-TNF treatment
Key clinical point: Inflammatory bowel disease patients on anti–tumor necrosis factor treatment often develop psoriasiform skin lesions. Major...
Conference Coverage
Select biologics for dose escalation in psoriasis
Article
Reducing Risks
Psoriasis is associated with multiple comorbidities, including cardiovascular diseases. With the advent of anti-inflammatory therapy, there has...
News
FDA panel unanimously supports secukinumab approval for psoriasis
Conference Coverage
Secukinumab showed sustained efficacy in psoriasis
Key clinical point: Psoriasis patients’ initial strong clinical response to the interleukin-17A inhibitor secukinumab is sustained through 52...